Albendazole therapy for eosinophilic meningitis caused by Angiostrongylus cantonensis (original) (raw)

Abstract

Eosinophilic meningitis in humans is commonly caused by the nematode Angiostrongylus cantonensis. A severe headache is the most common presenting symptom. A prospective, randomized, double-blind, placebo, controlled study was conducted to determine if albendazole was efficacious in relieving such headaches. Seventy-one patients (36 and 35 in the treatment and control groups) were enrolled in the study. Five patients (two and three in the treatment and control groups) were excluded from the study because of being lost to follow-up, and the clinical data were incomplete. Therefore, 34 and 32 patients in the treatment and control groups were studied, respectively. Albendazole was administered at 15 mg/kg/day or identical placebo for 2 weeks. The number of patients with persistent headaches after 2 weeks was 7 and 13 in the albendazole and placebo groups (p = 0.08), respectively. The mean duration of a headache was 8.9 and 16.2 days in the albendazole and placebo groups, respectively (p = 0.05). No serious drug events were observed. A 2-week course of albendazole appeared to reduce the duration of headache in eosinophilic meningitis.

Access this article

Log in via an institution

Subscribe and save

Buy Now

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

Download references

Acknowledgment

We would like to thank Professor Kiertjai Bhuripanyo for the study design advice, Assistant Professor Malinee Laopaiboon for statistical advice, SK & F (Thailand) for providing drug and identical placebo and the Grant support by the Faculty of Medicine, Khon Kaen University.

Author information

Authors and Affiliations

  1. Department of Medicine, Faculty of Medicine, Khon Kaen University, Khon Kaen, 40002, Thailand
    Suthipun Jitpimolmard & Kittisak Sawanyawisuth
  2. Department of Parasitology, Faculty of Medicine, Chiang Mai University, Chiang Mai, 50002, Thailand
    Nimit Morakote
  3. Department of Medicine, Faculty of Medicine, Mahidol University, Bangkok, Thailand
    Athasit Vejjajiva
  4. Department of Clinical Microscopy, Faculty of Associated Medical Sciences, Khon Kaen University, Khon Kaen, 40002, Thailand
    Montien Puntumetakul & Kanokwan Sanchaisuriya
  5. Department of Pharmacology, Faculty of Pharmacology, Khon Kaen University, Khon Kaen, 40002, Thailand
    Wongwiwat Tassaneeyakul & Wichittra Tassaneeyakul
  6. Department of Community Dentistry, Faculty of Dentistry, Chiangmai University, Chiang Mai, 50002, Thailand
    Narumanas Korwanich

Authors

  1. Suthipun Jitpimolmard
    You can also search for this author inPubMed Google Scholar
  2. Kittisak Sawanyawisuth
    You can also search for this author inPubMed Google Scholar
  3. Nimit Morakote
    You can also search for this author inPubMed Google Scholar
  4. Athasit Vejjajiva
    You can also search for this author inPubMed Google Scholar
  5. Montien Puntumetakul
    You can also search for this author inPubMed Google Scholar
  6. Kanokwan Sanchaisuriya
    You can also search for this author inPubMed Google Scholar
  7. Wongwiwat Tassaneeyakul
    You can also search for this author inPubMed Google Scholar
  8. Wichittra Tassaneeyakul
    You can also search for this author inPubMed Google Scholar
  9. Narumanas Korwanich
    You can also search for this author inPubMed Google Scholar

Corresponding author

Correspondence toKittisak Sawanyawisuth.

Rights and permissions

About this article

Cite this article

Jitpimolmard, S., Sawanyawisuth, K., Morakote, N. et al. Albendazole therapy for eosinophilic meningitis caused by Angiostrongylus cantonensis .Parasitol Res 100, 1293–1296 (2007). https://doi.org/10.1007/s00436-006-0405-7

Download citation

Keywords